Demystifying Infusion Pumps: Design of a Cost-Effective Platform for Education and Innovation
Academic Article in Scopus
-
- Overview
-
- Identity
-
- Additional document info
-
- View All
-
Overview
abstract
-
Introduction: This article presents a cost-effective, modular infusion platform to help diabetes specialists customize and understand infusion pump mechanics and control principles. Traditional insulin pumps are costly and inflexible, limiting accessibility, and particularly in low-resource settings. Inspired by open-source initiatives like OpenAPS, this platform engages specialists in device operation and customization, offering practical insights into infusion technology. Method: An initial survey assessed technological literacy, customization interests, and feature preferences among Mexican diabetes specialists, followed by a hands-on engagement session with the platform¿s hardware. Core components are described and chosen for reliability, affordability, and integration ease. A follow-up survey evaluated specialists¿ confidence and interest in device customization, gathering feedback on usability and design. Results: Survey data showed strong specialist interest in understanding device mechanics and high confidence in customization after hands-on engagement. Most specialists found the hardware layout conducive to experimentation, with significant interest in closed-loop capabilities. Key valued features included safety, affordability, ease of use, customization, and integration of diverse continuous glucose monitors, with added suggestions for potential clinical certification, cost-effective supplies, and artificial intelligence integration. Conclusion: This platform offers a promising educational and developmental tool in diabetes management, bridging clinical application, and customization. Its low-cost, modular design provides a feasible solution for low-resource settings, equipping specialists to tailor devices for specific patient needs. While the platform¿s educational potential is clear, further studies and validation are essential for a possible transition to a clinical-grade device. Continued development could democratize access to advanced diabetes technology, transforming specialist training, and patient care. © 2025 Diabetes Technology Society.
status
publication date
published in
Identity
Digital Object Identifier (DOI)
Additional document info
has global citation frequency